2011 Cancer Committee Members - Erlanger Health System

Prostate Cancer Study
1998–2002 Observed Survival National Data & Erlanger Data
1998 – 2002 Observed Survival for Prostate Cancer at the Erlanger Cancer Center
Cumulative
Survival Rate
Stage I
Stage II
Stage III
Stage IV *
0 year 1 year 2 year 3 year 4 year 5 year
Years from Diagnosis
Prostate Cancer Study
2000–2009 Stage of Prostate Cancer Diagnosed at Erlanger Health System
Versus Teaching Research Hospitals in All States
From 2000 through 2009, a total of 319 men with prostate cancer were entered into Erlanger Health System’s
cancer registry database. The stage of the tumor at the time of diagnosis is a measure of how far the
cancer has advanced. Stage 0 is the least advanced, while Stage IV is the most advanced. The graph below
shows the stages of tumors diagnosed at Erlanger Health System compared to the National Cancer Database
(NCDB) statistics on prostate stage at diagnosis. Of the cases diagnosed at Erlanger Health System, 1
(0.31%) were stage 0; 4 (1.25%) were stage I; 210 (65.83%) were stage II; 59 (18.5%) were stage III; and 37
(11.6%) were stage IV. There were 5 (1.57%) patients who were not staged or could not be staged. This data
compared to the NCDB statistics for this same period of time is as follows: 0% were stage 0; 1.28% were
stage I, 77.41% were stage II, 9.13% were stage III and 4.86% were stage IV.
24
Prostate Cancer
2000 – 2009 Stage of Prostate Cancer Diagnosed at
Erlanger versus Teaching Research Hospitals in All States
Percent (%)
100
80
60
40
20
0
0 I II III IV N/A UNK
Stage
Erlanger
Other